// App-Quantinova.ai

: Which factors influence the choice of a non-vitamin K oral anticoagulant over warfarin for stroke prevention among atrial fibrillation patients? Insights from the prospective SPRINT-AF registry

Researchers

Presenter

  • A. Shuaib

Principal Investigators

  • N. Singh

  • A. Ha

Medical Centers

  • University of Alberta, Medicine, Edmonton, Canada

  • Medical College of Georgia at Augusta university, Medicine, Augusta, United States of America

  • Univ Health Network, Peter Munk Cardiac Ctr, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Warfarin

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved